Last updated: April 20, 2022
Sponsor: Assistance Publique - Hôpitaux de Paris
Overall Status: Completed
Phase
N/A
Condition
Circulation Disorders
Dizzy/fainting Spells
Vascular Diseases
Treatment
N/AClinical Study ID
NCT02261792
P111118
2013-AO1017-38
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 18 years or more
- No contraindication for BPE
- Severe or moderate headache within 15 min standing, mild or no headache after 15 minbed rest
- Headache from 5 to 28 days
- Normal or evidence of low CSF on MRI
- Signed informed consent
Exclusion
Exclusion Criteria:
- Known dural leak in the previous 2 months the onset of headache
- Abnormal MRI
- First BPE for SIH
- The patient has participated in another clinical trial than can interact with theevaluation
- Contraindication of Trendelenburg position
Study Design
Total Participants: 64
Study Start date:
December 01, 2014
Estimated Completion Date:
March 08, 2021
Study Description
Connect with a study center
Lariboisiere Hospital - Centre Urgences Céphalées (CUC)
Paris, 75010
FranceSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.